 |
 |
 |
|
 |
|
 |
|
 |
           |
Meet the Team Management Team Xceed Molecular brings together a team of innovative and experienced leaders in developing and commercializing molecular diagnostic systems and tests for the growing market in translational medicine. Our senior management team has more than 100 years of combined experience bringing diagnostic instruments and IVD tests to market, and is drawn from "blue chip" companies including Abbott, Becton Dickinson, and Packard Bioscience.
Board of Directors
Advisors
Investors Xceed Molecular is a privately-held company whose shareholders include Vengrowth Capital, Cipio Partners and Ore Pharmaceuticals.
 For over 25 years, VenGrowth has provided Canadians with unique and specialized investment strategies. VenGrowth manages assets on behalf of more than 200,000 individual investors as well as leading institutional clients.  Ore Pharmaceuticals Inc. was incorporated in September 1994 as Gene Logic Inc. and headquartered in Gaithersburg, Maryland. In December 2007, the Company sold the assets of the Genomics Business and changed its name to Ore Pharmaceuticals Inc. to reflect its new identity as a drug development and indication discovery company. The Company’s stock is now traded on The NASDAQ Global Market under the symbol ORXE.  Cipio Partners is known as a leading international investment management firm in the secondary direct market. We were founded in June 2003 and currently manage several funds of early and later-stage venture capital and mid-market investments in various geographies worldwide. Our staff is based in Munich, London and San Jose, CA.
Scientific Advisory Board - Inflammatory Diseases
|
||||||||||||||||||||||
| home © 2009 Xceed Molecular For Research Use Only |
